Unibest 优贝德
← Back to patent-cliff list

琥珀酸瑞波西利

Tier A — Act now

Ribociclib Succinate · all drugs expiring in 2029 →

诺华制药
Originator
2017
First approval
2029
Expiry (public)
$4.78B ▲
Peak sales
化学药
Type

TargetsCDK6、CDK4

Brand凯丽隆、Kisqali

Indications (approved)乳腺癌

Regional status

US
批准上市
2017-03-13
EU
批准上市
2017-08-22
China
批准上市
2023-01-19
Japan
临床一期
2013-05-01

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 9 · Total yield 45.7 g
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
RIBO-00136082-50-5Available5-bromo-2,4-dichloropyrimidine
RIBO-0021003-03-8Availablecyclopentanamine
RIBO-003733039-20-8Available5-bromo-2-chloro-N-cyclopentylpyrimidin-4-amine
RIBO-004107-19-7Availableprop-2-yn-1-ol
RIBO-0051374639-76-5Available3-(2-chloro-4-(cyclopentylamino)pyrimidin-5-yl)prop-2-yn-1-ol
RIBO-0061374639-77-6Available(2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol
RIBO-007124-40-3Availabledimethylamine
RIBO-0081211443-61-6Available2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide
RIBO-009571188-59-5Availabletert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
RIBO-0101374639-78-7Availabletert-butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
RIBO-01152092-47-4Available5-chloro-2-nitropyridine
RIBO-012110-85-0Availablepiperazine
RIBO-013775288-71-6Available1-(6-nitropyridin-3-yl)piperazine
RIBO-014571189-16-7Availabletert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate

Frequently asked questions

What are the approved indications of Ribociclib Succinate?

Approved indications include: 乳腺癌.

When does the Ribociclib Succinate patent expire?

Based on public sources, the Ribociclib Succinate patent expires in 2029.

How many synthesis routes are recorded for Ribociclib Succinate?

1 synthesis routes are recorded; the shortest is 9 steps with 45.7 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Ribociclib Succinate intermediates?

14 intermediate CAS of Ribociclib Succinate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Ribociclib Succinate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24